Ikena Oncology Stock Price on March 12, 2024

IKNA Stock  USD 1.71  0.02  1.16%   
If you're considering investing in Ikena Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ikena Oncology stands at 1.71, as last reported on the 26th of November, with the highest price reaching 1.73 and the lowest price hitting 1.69 during the day. Ikena Oncology holds Efficiency (Sharpe) Ratio of -0.0159, which attests that the entity had a -0.0159% return per unit of risk over the last 3 months. Ikena Oncology exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ikena Oncology's Downside Deviation of 1.72, market risk adjusted performance of 0.0012, and Risk Adjusted Performance of 0.0079 to validate the risk estimate we provide.
  
At present, Ikena Oncology's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 54.2 M, whereas Common Stock is forecasted to decline to about 26.6 K. . At present, Ikena Oncology's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.51, whereas Price To Sales Ratio is forecasted to decline to 8.53. Ikena Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0159

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIKNA

Estimated Market Risk

 1.25
  actual daily
11
89% of assets are more volatile

Expected Return

 -0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Ikena Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ikena Oncology by adding Ikena Oncology to a well-diversified portfolio.
Price Book
0.6148
Enterprise Value Ebitda
(0.54)
Price Sales
125.2221
Shares Float
13.9 M
Wall Street Target Price
3

Ikena Oncology Valuation on March 12, 2024

It is possible to determine the worth of Ikena Oncology on a given historical date. On March 12, 2024 Ikena was worth 1.44 at the beginning of the trading date compared to the closed value of 1.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ikena Oncology stock. Still, in general, we apply an absolute valuation method to find Ikena Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ikena Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ikena Oncology's related companies.
 Open High Low Close Volume
  1.61    1.65    1.43    1.46    332,878  
03/12/2024
  1.44    1.50    1.36    1.39    399,977  
  1.40    1.43    1.38    1.41    363,518  
Backtest Ikena Oncology  |  Ikena Oncology History  |  Ikena Oncology Valuation   PreviousNext  
Open Value
1.44
1.39
Closing Value
5.19
Upside

Ikena Oncology Trading Date Momentum on March 12, 2024

On March 13 2024 Ikena Oncology was traded for  1.41  at the closing time. The top price for the day was 1.43  and the lowest listed price was  1.38 . The trading volume for the day was 363.5 K. The trading history from March 13, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 1.44% . The trading delta at closing time against the current closing price is 7.91% .

Ikena Oncology Fundamentals Correlations and Trends

By evaluating Ikena Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ikena Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ikena financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Ikena Oncology Stock history

Ikena Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ikena is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ikena Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ikena Oncology stock prices may prove useful in developing a viable investing in Ikena Oncology
Last ReportedProjected for Next Year
Common Stock Shares Outstanding41.7 M40.8 M
Net Loss-61.9 M-65 M

Ikena Oncology Quarterly Net Working Capital

141.12 Million

Ikena Oncology Stock Technical Analysis

Ikena Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ikena Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ikena Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Ikena Oncology Period Price Range

Low
November 26, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Ikena Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Ikena Oncology November 26, 2024 Market Strength

Market strength indicators help investors to evaluate how Ikena Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ikena Oncology shares will generate the highest return on investment. By undertsting and applying Ikena Oncology stock market strength indicators, traders can identify Ikena Oncology entry and exit signals to maximize returns

Ikena Oncology Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Ikena Oncology's price direction in advance. Along with the technical and fundamental analysis of Ikena Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ikena to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Ikena Stock analysis

When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios